BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shiba S, Shibuya K, Katoh H, Kaminuma T, Miyazaki M, Kakizaki S, Shirabe K, Ohno T, Nakano T. A comparison of carbon ion radiotherapy and transarterial chemoembolization treatment outcomes for single hepatocellular carcinoma: a propensity score matching study. Radiat Oncol 2019;14:137. [PMID: 31375120 DOI: 10.1186/s13014-019-1347-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Okazaki S, Shibuya K, Shiba S, Okamoto M, Miyasaka Y, Osu N, Kawashima M, Kakizaki S, Araki K, Shirabe K, Ohno T. Carbon ion radiotherapy for patients with hepatocellular carcinoma in the caudate lobe carbon ion radiotherapy for hepatocellular carcinoma in caudate lobe. Hepatol Res 2021;51:303-12. [PMID: 33350034 DOI: 10.1111/hepr.13606] [Reference Citation Analysis]
2 Ren Y, Cao Y, Ma H, Kan X, Zhou C, Liu J, Shi Q, Feng G, Xiong B, Zheng C. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study. BMC Cancer 2019;19:983. [PMID: 31640620 DOI: 10.1186/s12885-019-6237-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
3 Abousaida B, Seneviratne D, Hoppe BS, Ko SJ, Asaithamby A, Cucinotta FA, Kirwan JM, Mody K, Toskich B, Ashman JB, Hallemeier CL, Krishnan S. Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1169-79. [PMID: 34595139 DOI: 10.2147/JHC.S292516] [Reference Citation Analysis]
4 Malouff TD, Mahajan A, Krishnan S, Beltran C, Seneviratne DS, Trifiletti DM. Carbon Ion Therapy: A Modern Review of an Emerging Technology. Front Oncol 2020;10:82. [PMID: 32117737 DOI: 10.3389/fonc.2020.00082] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 21.0] [Reference Citation Analysis]
5 Osu N, Shiba S, Shibuya K, Okazaki S, Miyasaka Y, Okamoto M, Ohno T. Carbon-ion radiotherapy subsequent to balloon-occluded retrograde transvenous obliteration for hepatocellular carcinoma with hepatic encephalopathy: a multidisciplinary approach. Clin J Gastroenterol 2021;14:852-7. [PMID: 33811604 DOI: 10.1007/s12328-021-01395-6] [Reference Citation Analysis]
6 Takakusagi S, Takagi H, Shibuya K, Kosone T, Sato K, Kakizaki S, Ohno T, Uraoka T. Two elder cases of hepatocellular carcinoma adjacent to intrahepatic vessels successfully treated by carbon ion radiotherapy. Clin J Gastroenterol 2020;13:920-6. [PMID: 32529487 DOI: 10.1007/s12328-020-01151-2] [Reference Citation Analysis]
7 Kim KS, Wu HG. Who Will Benefit from Charged-Particle Therapy? Cancer Res Treat 2021;53:621-34. [PMID: 34176253 DOI: 10.4143/crt.2021.299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li Z, Li Q, Wang X, Li S, Chen W, Jin X, Liu X, Dai Z, Liu X, Zheng X, Li P, Zhang H, Zhang Q, Luo H, Liu R. Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis. Front Public Health 2021;9:767617. [PMID: 34957022 DOI: 10.3389/fpubh.2021.767617] [Reference Citation Analysis]
9 Shiba S, Parajuli RK, Sakai M, Oike T, Ohno T, Nakano T. Use of a Si/CdTe Compton Camera for In vivo Real-Time Monitoring of Annihilation Gamma Rays Generated by Carbon Ion Beam Irradiation. Front Oncol 2020;10:635. [PMID: 32509570 DOI: 10.3389/fonc.2020.00635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
10 Shiba S, Okamoto M, Kiyohara H, Okazaki S, Kaminuma T, Shibuya K, Kohama I, Saito K, Yanagawa T, Chikuda H, Nakano T, Ohno T. Impact of Carbon Ion Radiotherapy on Inoperable Bone Sarcoma. Cancers (Basel) 2021;13:1099. [PMID: 33806515 DOI: 10.3390/cancers13051099] [Reference Citation Analysis]
11 Duque AS, Corradini S, Kamp F, Seidensticker M, Streitparth F, Kurz C, Walter F, Parodi K, Verhaegen F, Ricke J, Belka C, Fonseca GP, Landry G. The dosimetric impact of replacing the TG-43 algorithm by model based dose calculation for liver brachytherapy. Radiat Oncol 2020;15:60. [PMID: 32151255 DOI: 10.1186/s13014-020-01492-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]